Pharmaceutical company i-Cordis has received $1.5 million through a Phase II Small Business Innovation Research grant from the National Heart, Lung, and Blood Institute.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,